Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsStephanos J. Hadziyannis, Steven L. Chuck, Zachary Goodman et al.|Gastroenterology|2006Cited by 882
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis BEugene R. Schiff, Steven L. Chuck, Ching‐Lung Lai et al.|Liver Transplantation|2007Cited by 236
P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapyS. Hadziyannis, Steven L. Chuck, N.C. Tassopoulos et al.|Journal of Clinical Virology|2006Cited by 59
483 Final analysis of virological outcomes and resistance during 5 years of adefovir dipivoxil monotherapy in HBeAg-negative patientsKatyna Borroto–Esoda, Jean–Michel Pawlotsky, A. Snow et al.|Journal of Hepatology|2006Cited by 19